Vivos Inc (RDGL)

[rtg123]

Contrary to what some may say RDGL is now in a great position. In the words of one of the most successful heads of research in big pharma, "Drug discovery/development in a bloody business. It's hard". I know medicinal chemists with 30+ years of experience that have never worked on a single compound that made it to market approval. I have a client who started on a device in 2008 and they are still not in the clinic. Dr K is not perfect but nevertheless did a great job getting us to where we are.

The FDA has suggested the EFS and we are now one preclinical study away from the IDE submission. They want to see Radiogel going into patients as much as we do. Safety is paramount to them so the containment study will help defining the top radioactive dose that can be administered. It is highly unlikely they will request another study.